Theravance Biopharma, Inc. (TBPH)
20.74
+0.37
(+1.82%)
USD |
NASDAQ |
Jan 22, 16:00
20.75
+0.01
(+0.05%)
After-Hours: 20:00
Theravance Biopharma Price: 20.74 for Jan. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Corcept Therapeutics, Inc. | 41.30 |
| Perspective Therapeutics, Inc. | 2.67 |
| Skye Bioscience, Inc. | 1.05 |
| Kyntra Bio, Inc. | 8.97 |
| Myomo, Inc. | 0.96 |
Price Related Metrics
| PE Ratio | 36.87 |
| PS Ratio | 13.02 |
| Price to Book Value | 4.517 |
| Price to Free Cash Flow | 4.294 |
| Earnings Yield | 2.71% |
| Market Cap | 1.051B |
| Normalized PE Ratio | 36.87 |